10CFU™ Sensitivity Standards for Mycoplasma arginini Reference: 102-1003 Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.
10CFU™ Sensitivity Standards for Mycoplasma orale Reference: 102-2003 Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.
10CFU™ Sensitivity Standards for Mycoplasma gallisepticum Reference: 102-3003 Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.
10CFU™ Sensitivity Standards for Mycoplasma pneumoniae Reference: 102-4003 Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.
10CFU™ Sensitivity Standards for Mycoplasma synoviae Reference: 102-5003 Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.
10CFU™ Sensitivity Standards for Mycoplasma fermentans Reference: 102-6003 Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.
10CFU™ Sensitivity Standards for Mycoplasma hyorhinis Reference: 102-7003 Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.
10CFU™ Sensitivity Standards for Mycoplasma laidlawii Reference: 102-8003 Contains 3 vials with 10 CFU each and 2 negative controls. For the validation of detection limit and robustness, individual sample material according to EP 2.6.7 with inactivated mycoplasma particles.